NeuroOne Medical Technologies Corp expected to post a loss of 22 cents a share - Earnings Preview

Neuroone Medical Technologies

11/08/2026 14:20

NeuroOne Medical Technologies Corp NMTC.OQ NMTC.O is expected to  show a rise in quarterly revenue when it reports  results on August 13 for the period ending June 30 2026
The Eden Prairie Minnesota-based  company is expected to report a 50.2% increase in revenue to $2.547 million from $1.7 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
​LSEG's mean analyst estimate for NeuroOne Medical Technologies Corp is for a loss of 22 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for NeuroOne Medical Technologies Corp is $8.80, about 464.1% above its last closing price of $1.56
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.14
-0.23
-0.25
Missed
-10.3
Dec. 31 2026
-0.24
-0.24
-0.18
Beat
25
Sep. 30 2025
-0.24
-0.24
-0.24
Met
0​
Jun. 30 2025
-0.30
-0.30
-0.18
Beat
40
​​
​
This summary was machine generated August 11 at 13:20 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)